{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:09:40Z","timestamp":1792271380748,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02100-1","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:41:12Z","timestamp":1759311672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diffuse leptomeningeal glioneuronal tumour: molecular diagnosis, evolution and treatment"],"prefix":"10.1186","volume":"13","author":[{"given":"Anastasia","family":"Campanelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"M\u00e9tais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Bouchoucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Beccaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Laprie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Blauwblomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelio","family":"Guida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Benichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Guerrini-Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Simbozel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnault","family":"Tauziede-Espariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Varlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura","family":"Sellami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Bolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Boddaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volodia","family":"Dangouloff-Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bourdeaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Doz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Grill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Abbou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2100_CR1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820","journal-title":"Acta Neuropathol"},{"key":"2100_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10014-014-0187-z","volume":"32","author":"HJ Cho","year":"2015","unstructured":"Cho HJ, Myung JK, Kim H, Park C-K, Kim S-K, Chung CK et al (2015) Primary diffuse leptomeningeal glioneuronal tumors. Brain Tumor Pathol 32:49\u201355","journal-title":"Brain Tumor Pathol"},{"key":"2100_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-017-1728-4","volume":"134","author":"JCH Chiang","year":"2017","unstructured":"Chiang JCH, Harreld JH, Orr BA, Sharma S, Ismail A, Segura AD et al (2017) Low-grade spinal glioneuronal tumors with BRAF gene fusion and 1p deletion but without leptomeningeal dissemination. Acta Neuropathol 134:159\u2013162","journal-title":"Acta Neuropathol"},{"key":"2100_CR4","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.3174\/ajnr.A6737","volume":"41","author":"DA Lakhani","year":"2020","unstructured":"Lakhani DA, Mankad K, Chhabda S, Feizi P, Patel R, Sarma A et al (2020) Diffuse leptomeningeal glioneuronal tumor of childhood. AJNR Am J Neuroradiol 41:2155\u20132159","journal-title":"AJNR Am J Neuroradiol"},{"key":"2100_CR5","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s00381-022-05600-w","volume":"38","author":"K Wi\u015bniewski","year":"2022","unstructured":"Wi\u015bniewski K, Brandel MG, Gonda DD, Crawford JR, Levy ML (2022) Prognostic factors in diffuse leptomeningeal glioneuronal tumor (DLGNT): a systematic review. Childs Nerv Syst 38:1663\u20131673","journal-title":"Childs Nerv Syst"},{"key":"2100_CR6","first-page":"441","volume":"34","author":"A Ozen","year":"2024","unstructured":"Ozen A, Tanrikulu B, Danyeli AE, Ozek MM (2024) Pediatric diffuse leptomeningeal glioneuronal tumors: diagnosis, Follow-up, and treatment options. Turk Neurosurg 34:441\u2013447","journal-title":"Turk Neurosurg"},{"key":"2100_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1750-3639.2009.00285.x","volume":"20","author":"MP Gardiman","year":"2010","unstructured":"Gardiman MP, Fassan M, Orvieto E, D\u2019Avella D, Denaro L, Calderone M et al (2010) Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol 20:361\u2013366","journal-title":"Brain Pathol"},{"key":"2100_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-018-1865-4","volume":"136","author":"MY Deng","year":"2018","unstructured":"Deng MY, Sill M, Chiang J, Schittenhelm J, Ebinger M, Schuhmann MU et al (2018) Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features. Acta Neuropathol 136:239\u2013253","journal-title":"Acta Neuropathol"},{"key":"2100_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/08880018.2019.1711270","volume":"37","author":"C Abongwa","year":"2020","unstructured":"Abongwa C, Cotter J, Tamrazi B, Dhall G, Davidson T, Margol A (2020) Primary diffuse leptomeningeal glioneuronal tumors of the central nervous system: report of three cases and review of literature. Pediatr Hematol Oncol 37:248\u2013258","journal-title":"Pediatr Hematol Oncol"},{"key":"2100_CR10","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231\u20131251","journal-title":"Neuro Oncol"},{"key":"2100_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-021-01248-w","volume":"9","author":"N Manoharan","year":"2021","unstructured":"Manoharan N, Ajuyah P, Senapati A, Wong M, Mullins A, Rodriguez M et al (2021) Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis. Acta Neuropathol Commun 9:147","journal-title":"Acta Neuropathol Commun"},{"key":"2100_CR12","doi-asserted-by":"crossref","unstructured":"M\u00e9tais A, Bouchoucha Y, Kergrohen T, Dangouloff-Ros V, Maynadier X, Ajlil Y, et al (2023) Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours. Acta Neuropathol. 145(1):83\u201395.","DOI":"10.1007\/s00401-022-02512-6"},{"key":"2100_CR13","first-page":"vdad049","volume":"5","author":"PJ Madsen","year":"2023","unstructured":"Madsen PJ, Hollawell ML, Santi M, Surrey LF, Vossough A, Orr BA et al (2023) Diffuse leptomeningeal glioneuronal tumor in a child masquerading as an intramedullary spinal pilocytic Astrocytoma. Neurooncol Adv 5:vdad049","journal-title":"Neurooncol Adv"},{"key":"2100_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00401-022-02507-3","volume":"144","author":"J Chiang","year":"2022","unstructured":"Chiang J, Moreira DC, Li X, Furtado LV (2022) Prognostic significance of chromosome arm 1q gain and methylation class in molecularly defined diffuse leptomeningeal glioneuronal tumor. Acta Neuropathol 144:1185\u20131187","journal-title":"Acta Neuropathol"},{"key":"2100_CR15","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1016\/S1470-2045(20)30064-4","volume":"21","author":"J Fangusaro","year":"2020","unstructured":"Fangusaro J, Witt O, Hern\u00e1iz Driever P, Bag AK, de Blank P, Kadom N et al (2020) Response assessment in paediatric low-grade glioma: recommendations from the response assessment in pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 21:e305\u2013e316","journal-title":"Lancet Oncol"},{"key":"2100_CR16","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1200\/JCO.2011.34.5843","volume":"30","author":"E Bouffet","year":"2012","unstructured":"Bouffet E, Jakacki R, Goldman S, Hargrave D, Hawkins C, Shroff M et al (2012) Phase II study of weekly vinblastine in recurrent or refractory pediatric Low-Grade glioma. JCO 30:1358\u20131363","journal-title":"JCO"},{"key":"2100_CR17","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/bcp.15131","volume":"88","author":"M Hamimed","year":"2022","unstructured":"Hamimed M, Gattacceca F, Andr\u00e9 N, Tresch-Bruneel E, Probst A, Chastagner P et al (2022) Pharmacokinetics of oral Vinorelbine in French children with recurrent or progressive primary low-grade glioma. Br J Clin Pharmacol 88:2096\u20132117","journal-title":"Br J Clin Pharmacol"},{"key":"2100_CR18","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/pbc.21270","volume":"49","author":"SL Khaw","year":"2007","unstructured":"Khaw SL, Coleman LT, Downie PA, Heath JA, Ashley DM (2007) Temozolomide in pediatric low-grade glioma. Pediatr Blood Cancer 49:808\u2013811","journal-title":"Pediatr Blood Cancer"},{"key":"2100_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejca.2017.04.019","volume":"81","author":"AK Gnekow","year":"2017","unstructured":"Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo null, Grill J et al (2017) A European randomised controlled trial of the addition of Etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (\u2264\u200916 years) low grade glioma - A final report. Eur J Cancer 81:206\u2013225","journal-title":"Eur J Cancer"},{"key":"2100_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1200\/JCO.1993.11.5.850","volume":"11","author":"RJ Packer","year":"1993","unstructured":"Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R et al (1993) Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 11:850\u2013856","journal-title":"J Clin Oncol"},{"key":"2100_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/cam4.1799","volume":"8","author":"N Zhukova","year":"2018","unstructured":"Zhukova N, Rajagopal R, Lam A, Coleman L, Shipman P, Walwyn T et al (2018) Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma. Cancer Med 8:40\u201350","journal-title":"Cancer Med"},{"key":"2100_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD et al (2018) Efficacy of larotrectinib in TRK Fusion-Positive cancers in adults and children. N Engl J Med 378:731\u2013739","journal-title":"N Engl J Med"},{"key":"2100_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","volume":"7","author":"A Drilon","year":"2017","unstructured":"Drilon A, Siena S, Ou S-HI, Patel M, Ahn MJ, Lee J et al (2017) Safety and antitumor activity of the multitargeted Pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1). Cancer Discov 7:400\u2013409","journal-title":"Cancer Discov"},{"key":"2100_CR24","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1093\/neuonc\/noac087","volume":"24","author":"AV Desai","year":"2022","unstructured":"Desai AV, Robinson GW, Gauvain K, Basu EM, Macy ME, Maese L et al (2022) Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). Neuro Oncol 24:1776\u20131789","journal-title":"Neuro Oncol"},{"key":"2100_CR25","doi-asserted-by":"publisher","first-page":"e464","DOI":"10.1097\/MPH.0000000000002598","volume":"45","author":"E Hanzlik","year":"2023","unstructured":"Hanzlik E, Archambault B, El-Dairi M, Schroeder K, Patel MP, Lipp ES et al (2023) Use of Trametinib in children and young adults with progressive Low-grade glioma and glioneuronal tumors. J Pediatr Hematol Oncol 45:e464\u2013e470","journal-title":"J Pediatr Hematol Oncol"},{"key":"2100_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00381-017-3584-x","volume":"34","author":"D Aguilera","year":"2018","unstructured":"Aguilera D, Castellino RC, Janss A, Schniederjan M, McNall R, MacDonald T et al (2018) Clinical responses of patients with diffuse leptomeningeal glioneuronal tumors to chemotherapy. Childs Nerv Syst 34:329\u2013334","journal-title":"Childs Nerv Syst"},{"key":"2100_CR27","doi-asserted-by":"publisher","first-page":"107265","DOI":"10.1016\/j.clineuro.2022.107265","volume":"218","author":"VM Lu","year":"2022","unstructured":"Lu VM, Di L, Gernsback J, Eichberg DG, Luther EM, Shah AH et al (2022) Contemporary outcomes of diffuse leptomeningeal glioneuronal tumor in pediatric patients: A case series and literature review. Clin Neurol Neurosurg 218:107265","journal-title":"Clin Neurol Neurosurg"},{"key":"2100_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.clon.2018.11.032","volume":"31","author":"T Ajithkumar","year":"2019","unstructured":"Ajithkumar T, Taylor R, Kortmann RD (2019) Radiotherapy in the management of paediatric Low-Grade gliomas. Clin Oncol (R Coll Radiol) 31:151\u2013161","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2100_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1470-2045(04)01507-4","volume":"5","author":"RK Mulhern","year":"2004","unstructured":"Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE (2004) Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5:399\u2013408","journal-title":"Lancet Oncol"},{"key":"2100_CR30","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.3390\/cancers13143538","volume":"13","author":"K Weusthof","year":"2021","unstructured":"Weusthof K, L\u00fcttich P, Regnery S, K\u00f6nig L, Bernhardt D, Witt O et al (2021) Neurocognitive outcomes in pediatric patients following brain irradiation. Cancers (Basel) 13:3538","journal-title":"Cancers (Basel)"},{"key":"2100_CR31","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1093\/neuonc\/noae064.617","volume":"26","author":"C Satragno","year":"2024","unstructured":"Satragno C, Kieffer V, Dufour C, Martin V, Sellami N, Lanfranchi F et al (2024) QOL-29. Cognitive development within two years after craniospinal irradiation in children treated for medulloblastoma: A comprehensive assessment using age-appropriate scales. Neuro Oncol 26:0","journal-title":"Neuro Oncol"},{"key":"2100_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fonc.2017.00166","volume":"7","author":"E Doger de Speville","year":"2017","unstructured":"Doger de Speville E, Robert C, Perez-Guevara M, Grigis A, Bolle S, Pinaud C et al (2017) Relationships between regional radiation doses and cognitive decline in children treated with Cranio-Spinal irradiation for posterior fossa tumors. Front Oncol 7:166","journal-title":"Front Oncol"},{"key":"2100_CR33","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1001\/jama.297.24.2705","volume":"297","author":"MM Geenen","year":"2007","unstructured":"Geenen MM, Cardous-Ubbink MC, Kremer LCM, van den Bos C, van der Pal HJH, Heinen RC et al (2007) Medical assessment of adverse health outcomes in Long-term survivors of childhood cancer. JAMA 297:2705\u20132715","journal-title":"JAMA"},{"key":"2100_CR34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ctrv.2009.06.004","volume":"35","author":"RL Mulder","year":"2009","unstructured":"Mulder RL, Kremer LCM, van Santen HM, Ket JL, van Trotsenburg ASP, Koning CCE et al (2009) Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: A systematic review. Cancer Treat Rev 35:616\u2013632","journal-title":"Cancer Treat Rev"},{"key":"2100_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","volume":"20","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N et al (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20:1011\u20131022","journal-title":"Lancet Oncol"},{"key":"2100_CR36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1158\/1078-0432.CCR-24-0581","volume":"31","author":"A-A Lamoureux","year":"2025","unstructured":"Lamoureux A-A, Fisher MJ, Lemelle L, Pfaff E, Amir-Yazdani P, Kramm C et al (2025) Clinical characteristics and outcomes of central nervous system tumors harboring NTRK gene fusions. Clin Cancer Res 31:561\u2013572","journal-title":"Clin Cancer Res"},{"key":"2100_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40478-020-00978-7","volume":"8","author":"R Appay","year":"2020","unstructured":"Appay R, Pages M, Colin C, Jones DTW, Varlet P, Figarella-Branger D (2020) Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases. Acta Neuropathol Commun 8:95","journal-title":"Acta Neuropathol Commun"},{"key":"2100_CR38","doi-asserted-by":"publisher","first-page":"e823","DOI":"10.1210\/clinem\/dgad097","volume":"108","author":"M Rosimont","year":"2023","unstructured":"Rosimont M, Kariyawasam D, Samara-Boustani D, Giani E, Beltrand J, Bolle S et al (2023) Assessment of puberty and Hypothalamic-Pituitary-Gonadal axis function after childhood brain tumor treatment. J Clin Endocrinol Metab 108:e823\u2013e831","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR39","doi-asserted-by":"publisher","first-page":"e2156","DOI":"10.1210\/clinem\/dgab893","volume":"107","author":"LG Gonz\u00e1lez Brice\u00f1o","year":"2022","unstructured":"Gonz\u00e1lez Brice\u00f1o LG, Kariyawasam D, Samara-Boustani D, Giani E, Beltrand J, Bolle S et al (2022) High prevalence of early endocrine disorders after childhood brain tumors in a large cohort. J Clin Endocrinol Metab 107:e2156\u2013e2166","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR40","doi-asserted-by":"crossref","unstructured":"Morin A, Allodji R, Kariyawasam D, Touraine P, Puget S, Beccaria K et al (2024) Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study. Neuro Oncol. 26(7):1310\u20131324","DOI":"10.1093\/neuonc\/noae045"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02100-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02100-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02100-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:41:14Z","timestamp":1759311674000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02100-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2100"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02100-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6597257\/v1","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Parents or guardians gave consent for a retrospective analysis according to the institutional review board of Gustave Roussy (IRB: N\u00b0 2024\u2009\u2212\u2009446).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"S.A.: FORE pharmaceutical, Lilly and Ipsen: research funding support as a consultant. Patent for oral suspension of temozolomide. Y.B.: Institut ServierOther authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}